Stay updated on Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT03302234; the content appears unchanged between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T05:17:19.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    1%
    Check dated 2025-10-06T16:00:21.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Updated to v3.1.0 and removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a narrowing of content coverage. The page now reflects the new revision but loses these topics.
    Difference
    0.2%
    Check dated 2025-09-29T09:56:06.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Version label updated from v3.0.1 to v3.0.2; the Back to Top link was removed.
    Difference
    0.1%
    Check dated 2025-09-15T00:19:39.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, and a 'Back to Top' feature has been added.
    Difference
    0.1%
    Check dated 2025-09-07T20:44:56.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous specific locations across various countries and the removal of some previously listed locations. Additionally, there are new entries related to drug safety and pharmaceutical preparations.
    Difference
    16%
    Check dated 2025-08-31T12:59:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.